What to Expect from Cymer

Cymer (Nasdaq: CYMI  ) is expected to report Q4 earnings around Feb. 2. Here's what Wall Street wants to see:

The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Cymer's revenues will wither -10.0% and EPS will wane -92.5%.

The average estimate for revenue is $137.6 million. On the bottom line, the average EPS estimate is $0.03.

Revenue details
Last quarter, Cymer logged revenue of $131.5 million. GAAP reported sales were 2.2% higher than the prior-year quarter's $128.7 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Last quarter, EPS came in at $0.31. GAAP EPS of $0.31 for Q3 were 14% lower than the prior-year quarter's $0.36 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
For the preceding quarter, gross margin was 54.6%, 400 basis points better than the prior-year quarter. Operating margin was 6.9%, 350 basis points worse than the prior-year quarter. Net margin was 7.5%, 120 basis points worse than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $573.3 million. The average EPS estimate is $1.20.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 99 members out of 122 rating the stock outperform, and 23 members rating it underperform. Among 38 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 36 give Cymer a green thumbs-up, and two give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cymer is hold, with an average price target of $54.00.

Is Cymer the best semiconductor stock for you? You may be missing something obvious. Check out the semiconductor company that Motley Fool analysts expect to lead "The Next Trillion-dollar Revolution." Click here for instant access to this free report.

• Add Cymer to My Watchlist.